David B. Berkowitz 


 
Professor Berkowitz David B. Berkowitz Ph.D. 1990, Harvard University; Traveling Scholar, ETH-Zurich; 1986-1990; Merck Postdoctoral Fellow, Yale University (1990-1991); Alfred P. Sloan Research Fellow (1997-2001). 

Tel. (402) 472-2738. Fax. (402) 472-9402. Internet: dbb@unlserve.unl.edu

Publications
The Berkowitz Group


The Berkowitz group addresses issues at the interface of organic chemistry and enzymatic chemistry. On the one hand, enzymes are used as reagents for organic synthesis. For example (Scheme 1), an enzyme performs a key step in our asymmetric synthesis of the natural product, (-)-podophyllotoxin. This compound serves as the aglycon for Etoposide, a widely used chemotherapeutic drug. Recently, the project has also led to a fundamentally new "reverse Kahne glycosylation" strategy for constructing glycoconjugates with electron rich aglycons. Our synthesis is deliberately modular in ring E, and is being used to better define how the drug binds to its target, topoisomerase II.

The group is also actively developing new classes of mechanism-based enzyme inhibitors and metabolically stable substrate analogues. For example, several new classes of a-branched amino acids, including a-oxiranyl-, a-(2Z-fluoro)vinyl-, a-(1-fluoro)vinyl AA's have been synthesized for the first time, and examined for their ability to inhibit AADC's (amino acid decarboxylases). This project includes a significant component of enantioselective synthesis {(1) chiral auxiliary-mediated (Scheme 2); (2) self-reproduction of chirality; and (3) enzyme-assisted approaches are all being examined}. Students also have the opportunity to purify their target enzymes and characterize the nature of the inhibition with a variety of techniques (including UV- or radiolabel-based kinetics, and heteronuclear NMR).
 
 


































There is also a significant effort to develop and study novel, metabolically stable phosphate mimics. In recent years, we have focused on the a-mono- and difluorinated phosphonates as both pseudo-substrates (Scheme 3) and slow-binding inhibitors for phosphate-processing enzymes. Through this work, we seek to better define the optimal features required for mimicking either the substrate or the transition state in such active sites.

  • Selected Recent Publications:
  • Back to Top of page

    Back to UNL Chemistry Faculty Page

    Back to UNL Chemistry Home Page